Should Total Number of Lymph Nodes be Used as a Quality of Care Measure for Stage III Colon Cancer?
Authors:
- Jiping WangJWJiping Wang
- Mahmoud KulaylatMKMahmoud Kulaylat
- Howard RocketteHRHoward Rockette
- James HassettJHJames Hassett
- Ashwani RajputARAshwani Rajput
- Kelli Bullard DunnKDKelli Bullard Dunn
- Merril DaytonMDMerril Dayton
- 1 April 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 249 (4) , 559-563
Abstract
To assess whether TNODS is an independent prognostic factor after adjusting for the lymph node ratio (LNR). The medical literature has suggested that the TNODS is associated with better survival in stage II and III colon cancer. Thus TNODS was endorsed as a quality measure for patient care by American College of Surgeons, National Quality Forum. There is, however, little biologic rationale to support this linkage. : A total of 24,477 stage III colon cancer patients were identified from Surveillance, Epidemiology, and End Results cancer registry and categorized into 4 groups, LNR1 to LNR4, according to LNR interval: 0.50. Patients were also stratified according to TNODS into high TNODS (> or = 12) and low TNODS (<12) groups. The method of Kaplan-Meier was used to estimate the 5-year survival and the log-rank test was used to test the survival difference among the different groups. Patients with high TNODS have better survival compared with those with low TNODS (5-year survival 51.0% vs. 45.0%, P < 0.0001). However, after stratifying by LNR status, there was no significant survival difference between patients with high TNODS and those with low TNODS within strata LNR2 (5-year survival 56.3% vs. 56.0%, P = 0.26). Ironically, patients with high TNODS had significantly worse survival than those with low TNODS within strata LNR3 (5-year survival 41.2% vs. 47.4%, P = 0.0009) and LNR 4 (5-year survival 22.0% vs. 32.1%, P < 0.0001). The previously reported prognostic effect of TNODS on node-positive colon cancer was confounded by LNR. This observation calls into question the use of TNODS as a quality measure for colon cancer patients' care.Keywords
This publication has 34 references indexed in Scilit:
- Impact of lymph node retrieval and pathological ultra‐staging on the prognosis of stage II colon cancerJournal of Surgical Oncology, 2003
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Accuracy of Determining Nodal Negativity in Colorectal Cancer on the Basis of the Number of Nodes Retrieved on ResectionAnnals of Surgical Oncology, 2003
- The Prognosis of T3N0 Colon Cancer Is Dependent on the Number of Lymph Nodes ExaminedAnnals of Surgical Oncology, 2003
- Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal CancerJournal of Clinical Oncology, 2001
- American Joint Committee on Cancer prognostic factors consensus conferenceCancer, 2000
- American Joint Committee on Cancer Prognostic Factors Consensus ConferenceCancer, 1999
- Number of Nodes Examined and Staging Accuracy in Colorectal CarcinomaJournal of Clinical Oncology, 1999
- For patients with dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is Related to poor prognosisCancer, 1998
- Lymph Node Recovery From Colorectal Resection Specimens Removed for Adenocarcinoma:Trends Over Time and a Recommendation for a Minimum Number of Lymph Nodes to be RecoveredAmerican Journal of Clinical Pathology, 1996